Madhya Bharat Agro Products Q2 FY26: Capex ₹400 Cr
Q2 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹450Cr
- +61.9% YoY
- +9.8% QoQ
- Net profit
- ₹30Cr
- +114.3% YoY
- +7.1% QoQ
- Margin
- 14%
- +1 pp YoY
- 0 pp QoQ
Guidance rank: #3 of 23 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
The short version
H2 FY '26 is expected to have revenue similar to H1 FY '26 (~₹860 crore), not at the same high growth rate but maintaining production capacity utilization. H1 FY26 PAT increased by 132% YoY to ₹59 crore, with EPS doubling to ₹6.7, reflecting strong profitability.
From M B Agro Prod.'s Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- H2 FY '26 is expected to have revenue similar to H1 FY '26 (~₹860 crore), not at the same high growth rate but maintaining production capacity utilization.
- Total fertilizer production capacity will more than double to approximately 1.2 million tons by September 2026 due to expansions at Sagar (March ’26) and Dhule (September ’26).
- Strong sales growth expected from NPK fertilizers, which contribute higher EBITDA per ton (~₹6,000) compared to SSP (~₹1,800).
- SSP and NPK volumes sold in H1 FY '26 were 1,18,418 MT and 1,16,288 MT respectively, with strong demand projected to continue.
- Post capacity expansions, strong performance and volume growth anticipated over the coming years.
2 more points from M B Agro Prod.'s call on revenue
Create a free account to keep reading this call
Profitability & Margins
H1 FY26 PAT increased by 132% YoY to ₹59 crore, with EPS doubling to ₹6.7, reflecting strong profitability.
Locked: what M B Agro Prod. said on margins
Also locked on this page: fundraising, order book
Free account, 30 seconds. No card needed.
Capital Expenditure Plans
- Current CAPEX for FY '26: Approximately ₹400 crore, focusing on ongoing capacity expansions.
- Total CAPEX for Sagar and Dhule projects: Around ₹700 crore in fixed assets; ₹200 crore already spent, ₹200 crore expected by March 2026, balance in first half of FY '27.
- Funding: Combination of debt (around ₹430 crore in term loans with most sanctions in place) and internal accruals.
- Expansion projects:
- Sagar (Madhya Pradesh): Capacity expansion of 90,000 MTPA DAP/NPK and 1,65,000 MTPA sulfuric acid, to be commissioned by March 2026.
2 more points from M B Agro Prod.'s call on capex
Create a free account to keep reading this call
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
The company plans a total CAPEX of around ₹700 crore for Sagar and Dhule projects.
Locked: what M B Agro Prod. said on fundraising
Also locked on this page: margins, order book
Free account, 30 seconds. No card needed.
Order Book & Pipeline
See what M B Agro Prod. said on order book & pipeline — free account, 30 seconds.
M B Agro Prod. — Quarterly revenue & net profit
M B Agro Prod. Q2 FY26 results — key figures
| ₹ Cr | Q2 FY26 |
|---|---|
| Revenue | 450 |
| Operating profit (EBITDA) | 62 |
| Operating margin | 13.7% |
| Profit before tax | 49 |
| Net profit (PAT) | 30 |
| EPS (₹) | 3.48 |
Source: M B Agro Prod.'s results filing to NSE (standalone), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹416 Cr, net profit ₹33 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Madhya Bharat Agro Products's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
Earlier calls (2)
Others in Fertilizers & Agrochemicals this season
- Bhagiradha Chemicals & Industries (Q2 FY26)
140.1 crore, up 35% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q2 FY26 investor presentation — and how it ran
- Khaitan Chemical (Q2 FY26)
Q2-FY26 Operational Revenue: INR 3,086 million, up 33.8% year-on-year (Q2-FY25: INR 2,306 million). Key investor presentation takeaways from Khaitan Chemical's
- Rama Phosphates (Q2 FY26)
Revenue from Operations for Q2 FY26: ₹24,566 Lacs . Key investor presentation takeaways from Rama Phosphates's Q2 FY26 investor presentation — and how it ranks
- Krishana Phoschem (Q2 FY26)
Trading contributes around 20%–22% of total turnover; trading volumes may vary depending on market conditions. Key concall takeaways from Krishana Phoschem…
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Insecticides IndiaGood growth2
- Anya Polytech &Good growth1
- 3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
M B Agro Prod. and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were M B Agro Prod. Q2 FY26 results?
H2 FY '26 is expected to have revenue similar to H1 FY '26 (~₹860 crore), not at the same high growth rate but maintaining production capacity utilization. H1 FY26 PAT increased by 132% YoY to ₹59 crore, with EPS doubling to ₹6.7, reflecting strong profitability.
What is M B Agro Prod. share price analysis?
M B Agro Prod. currently shows a neutral. The stock trades at a P/E of 47.6 with a market cap of ₹7,381 Cr. Investors should review the full earnings analysis for detailed insights.
Is M B Agro Prod. planning capital expenditure?
Current CAPEX for FY '26: Approximately ₹400 crore, focusing on ongoing capacity expansions.
Keep M B Agro Prod. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
